Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.21)
# 2,837
Out of 5,242 analysts
311
Total ratings
59.03%
Success rate
-0.12%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMWL American Well | Maintains: Equal-Weight | $6 → $6.5 | $7.89 | -17.62% | 7 | May 6, 2026 | |
| WAY Waystar Holding | Initiates: Equal-Weight | $28 | $19.21 | +45.76% | 1 | Mar 30, 2026 | |
| OMDA Omada Health | Maintains: Overweight | $32 → $30 | $16.52 | +81.60% | 2 | Mar 6, 2026 | |
| VEEV Veeva Systems | Maintains: Equal-Weight | $205 → $215 | $164.96 | +30.33% | 11 | Mar 5, 2026 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $23.04 | -8.85% | 5 | Feb 25, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.52 | +58.73% | 3 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $396.67 | +7.14% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.45 | +26.98% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $54.74 | +22.40% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $216.89 | -33.61% | 15 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $175 → $210 | $187.41 | +12.05% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $164.32 | +21.71% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $0.8593 | +481.87% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $74.35 | +53.33% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $47.74 | +19.40% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $94.02 | -13.85% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $19.86 | +76.23% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $23.42 | -23.14% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $98.78 | +87.29% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $201.39 | -17.08% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $123.05 | -65.87% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $193.75 | -17.94% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $93.28 | +34.01% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $417.76 | -82.69% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $304.88 | -36.04% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $383.30 | +27.32% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $182.24 | +62.42% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $257.42 | +42.96% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $304.10 | +68.69% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $283.10 | -2.86% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $58.28 | +51.00% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $110.21 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $129.82 | +42.51% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $310.15 | -31.32% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $137.18 | -57.72% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $398.05 | -70.61% | 15 | Jun 16, 2020 |
American Well
May 6, 2026
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $7.89
Upside: -17.62%
Waystar Holding
Mar 30, 2026
Initiates: Equal-Weight
Price Target: $28
Current: $19.21
Upside: +45.76%
Omada Health
Mar 6, 2026
Maintains: Overweight
Price Target: $32 → $30
Current: $16.52
Upside: +81.60%
Veeva Systems
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $205 → $215
Current: $164.96
Upside: +30.33%
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $23.04
Upside: -8.85%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.52
Upside: +58.73%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $396.67
Upside: +7.14%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.45
Upside: +26.98%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $54.74
Upside: +22.40%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $216.89
Upside: -33.61%
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $187.41
Upside: +12.05%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $164.32
Upside: +21.71%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $0.8593
Upside: +481.87%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $74.35
Upside: +53.33%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $47.74
Upside: +19.40%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $94.02
Upside: -13.85%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $19.86
Upside: +76.23%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $23.42
Upside: -23.14%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $98.78
Upside: +87.29%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $201.39
Upside: -17.08%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $123.05
Upside: -65.87%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $193.75
Upside: -17.94%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $93.28
Upside: +34.01%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $417.76
Upside: -82.69%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $304.88
Upside: -36.04%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $383.30
Upside: +27.32%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $182.24
Upside: +62.42%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $257.42
Upside: +42.96%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $304.10
Upside: +68.69%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $283.10
Upside: -2.86%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $58.28
Upside: +51.00%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $110.21
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $129.82
Upside: +42.51%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $310.15
Upside: -31.32%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $137.18
Upside: -57.72%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $398.05
Upside: -70.61%